Works by Lei, Alejhandra

Results: 10
    1

    Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany.

    Published in:
    Clinical Drug Investigation, 2022, v. 42, n. 4, p. 319, doi. 10.1007/s40261-022-01120-2
    By:
    • Rivero-Ferrer, Elena;
    • Olesen, Morten;
    • Plana, Estel;
    • Aguado, Jaume;
    • Saigí-Morgui, Núria;
    • Rubino, Annalisa;
    • Daoud, Sami Z.;
    • Lei, Alejhandra;
    • Perez-Gutthann, Susana;
    • Schink, Tania;
    • Kristiansen, Nina Sahlertz;
    • Hallas, Jesper;
    • Pottegård, Anton;
    • Rebordosa, Cristina
    Publication type:
    Article
    2
    3
    4
    5
    6

    A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability After Subcutaneous Administration of Tozorakimab in Healthy Chinese Participants.

    Published in:
    Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 665, doi. 10.1002/cpdd.1391
    By:
    • Li, Yunfei;
    • Zhang, Hua;
    • Pandya, Hitesh;
    • Miao, Liyan;
    • Reid, Fred;
    • Jimenez, Eulalia;
    • Sadiq, Muhammad Waqas;
    • Moate, Rachel;
    • Lei, Alejhandra;
    • Zhou, Xiao‐Hong;
    • Kell, Chris;
    • Ding, Junjie;
    • Zhang, Guanlin;
    • Zhao, Lina;
    • Ge, Xiaoyun
    Publication type:
    Article
    7
    8

    A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink.

    Published in:
    International Journal of COPD, 2021, v. 16, p. 1461, doi. 10.2147/COPD.S301624
    By:
    • Rebordosa, Cristina;
    • Plana, Estel;
    • Rubino, Annalisa;
    • Aguado, Jaume;
    • Lei, Alejhandra;
    • Daoud, Sami;
    • Saigi-Morgui, Nuria;
    • Perez-Gutthann, Susana;
    • Rivero-Ferrer, Elena
    Publication type:
    Article
    9

    AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study.

    Published in:
    CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2494, doi. 10.1111/cts.13624
    By:
    • van Laar, Jacob M.;
    • Lei, Alejhandra;
    • Safy‐Khan, Mary;
    • Almquist, Joachim;
    • Belfield, Graham;
    • Edman, Karl;
    • Öberg, Lisa;
    • Angermann, Bastian R.;
    • Dillmann, Inken;
    • Berntsson, Pia;
    • Etal, Damla;
    • Dainty, Ian;
    • Astbury, Carol;
    • Belvisi, Maria G.;
    • Nemes, Szilárd;
    • Platt, Adam;
    • Prothon, Susanne;
    • Samuelsson, Sara;
    • Svanberg, Petter;
    • Keen, Christina
    Publication type:
    Article
    10

    A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease.

    Published in:
    Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 565, doi. 10.1002/cpt.3147
    By:
    • Reid, Fred;
    • Singh, Dave;
    • Albayaty, Muna;
    • Moate, Rachel;
    • Jimenez, Eulalia;
    • Sadiq, Muhammad Waqas;
    • Howe, David;
    • Gavala, Monica;
    • Killick, Helen;
    • Williams, Adam;
    • Krishnan, Surekha;
    • Godwood, Alex;
    • Shukla, Animesh;
    • Hewitt, Lisa;
    • Lei, Alejhandra;
    • Kell, Chris;
    • Pandya, Hitesh;
    • Newcombe, Paul;
    • White, Nicholas;
    • Scott, Ian C.
    Publication type:
    Article